A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy
Yixin Liu(Shanghai Jiao Tong University), Lishuang Qi(Harbin Medical University), Yunyan Gu(Harbin Medical University), Sainan Zhang(Wuhan University), Zheng Guo(Harbin Medical University), Zheyang Zhang(Harbin Medical University), Ying Li(Xian Yang Central Hospital), Tianhao Li(Harbin Medical University), Xin Li(Harbin Medical University), Wenyuan Zhao
Cited by 6
Related Papers
LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression
|Molecular Cancer|2018|384
Long noncoding RNA SNHG17 induced by YY1 facilitates the glioma progression through targeting miR-506-3p/CTNNB1 axis to activate Wnt/β-catenin signaling pathway
|Cancer Cell International|2020|55
An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy
|British Journal of Cancer|2016|50
An individualized gene expression signature for prediction of lung adenocarcinoma metastases
|Molecular Oncology|2017|47
Effectiveness and Safety of Acupuncture Combined with Madopar for Parkinson—s Disease: A Systematic Review with Meta-Analysis
|Acupuncture in Medicine|2017|36